GEDi Cube and Renovaro Biosciences Sign Definitive Agreement to Combine
Combined company aims to accelerate precision, personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early...
Healthcare
Hologic to Expand Outreach During Breast Cancer Awareness Month
Launches Global Partnership With Know Your Lemons, Will Ring Nasdaq Opening Bell for 17th TimeMARLBOROUGH, Mass.--(BUSINESS WIRE)--$HOLX #bcam--Hologic, Inc. (Nasdaq:...
Infinx Healthcare Recognized as a Sample Vendor for Intelligent Prior Authorization for Second Year in a Row in the Gartner Hype Cycle for U.S. Healthcare Payers, 2023
Gartner Hype Cycle Recognizes Infinx Healthcare as a Sample Vendor for Intelligent Prior AuthorizationNEW YORK, NY / ACCESSWIRE / September...
Odronextamab BLA for Treatment of Relapsed/Refractory Follicular Lymphoma (FL) and Diffuse Large B-cell Lymphoma (DLBCL) Accepted for FDA Priority Review
If approved, odronextamab would be the first and only bispecific antibody approved in both FL and DLBCL – the two...
Akari Therapeutics Reports First Half 2023 Financial Results and Highlights
Akari’s priority pipeline programs remain on track to begin enrollment in the registrational nomacopan Phase 3 clinical trials in pediatric...
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
EDISON, N.J., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on artificial...
Dentsply Sirona Announces Planned Board Succession
CHARLOTTE, N.C., Sept. 29, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced that,...
SciSparc Initiated Its Clinical Trial with SCI-210 in Pediatrics with Autism Spectrum Disorder
TEL AVIV, Israel, Sept. 29, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical...
Structure Therapeutics Announces $300 Million Private Placement Equity Financing
$300 million financing includes significant participation from a number of large healthcare dedicated institutional and mutual fund investors Net proceeds,...
Codexis CEO Stephen Dilly Wins Prestigious 2023 Bloom Burton Award
Stephen Dilly Headshot Stephen Dilly, MBBS, PhD, President & CEO of Codexis, Inc.REDWOOD CITY, Calif., Sept. 29, 2023 (GLOBE NEWSWIRE)...
AMBU FINANCIAL CALENDAR FOR 2023/24
This financial calendar lists the expected release dates of Ambu’s financial announcements for the financial year 2023/24, as well as...
Vaccinex Announces Pricing of $9.6 Million Public Offering
ROCHESTER, N.Y., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company...
Tonix Pharmaceuticals Announces Pricing of $4.5 Million Public Offering
CHATHAM, N.J., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a biopharmaceutical...
TFF Pharmaceuticals to Participate in Upcoming Investor Conferences
FORT WORTH, Texas, Sept. 28, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing...
QIAGEN extends AI capabilities of its NGS interpretation software QCI Interpret to enable clinical exome completeness
AI-driven literature extraction for thousands of rare disease genes fortifies and extends QIAGEN’s proprietary, human-certified content, providing complete bibliographic coverage...
Inventiva reports its 2023 first-half financial results and provides a corporate update
Cash and cash equivalents at €31.2 million, short-term deposits at €0.05 million1, and long-term deposit at €9.3 million2, as of...
Therma Bright Announces Change of Auditor
Toronto, Ontario--(Newsfile Corp. - September 29, 2023) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer...
Stephen Dilly Receives the 2023 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - September 29, 2023) - Bloom Burton & Co. ("Bloom Burton") is pleased to announce Stephen Dilly,...
Novo Integrated Sciences Signs Master Collateral Transfer Agreement
One Billion Dollar Collateral Transfer through Blacksheep TrustBELLEVUE, Wash.--(BUSINESS WIRE)--$NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”),...
Cloud DX Wins Competitive RFP, Signs Contract with Alberta Health Services
Cloud DX can now deliver digital Remote Patient Monitoring (dRPM) solutions to clients via Hospitals and via the Central Zone...